TORONTO–(BUSINESS WIRE)–Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”),
a leading provider of Transcranial Magnetic Stimulation (“TMS”)
therapy in the United States, is pleased to announce that it will
participate and present at the Bloom Burton & Co. Healthcare Conference
in Toronto on April 30th to May 1st, 2019.
Mr. Bill Leonard, President and Chief Executive Officer will present a
corporate overview and the Company’s growth plans for 2019 and beyond.
Greenbrook’s presentation details are:
When: Wednesday May 1st, 2019
Time: 10:30 a.m. Eastern time
Where: Metro Toronto Convention Centre, 255 Front Street West,
About the Conference
The Bloom Burton & Co. Healthcare Investor Conference brings together
U.S., Canadian and International investors who are interested in the
latest developments in the Canadian healthcare sector. Attendees will
have an opportunity to obtain corporate updates from the premier
Canadian publicly traded and private companies through presentations and
About Bloom Burton & Co.
Bloom Burton & Co. (Bloom Burton Securities Inc.) is a firm dedicated to
accelerating returns in the healthcare sector for both investors and
companies. Bloom Burton has an experienced team of medical, scientific,
pharmaceutical, legal and capital markets professionals who perform a
deep level of diligence, which combined with our creative and
entrepreneurial approach, assists our clients in achieving the right
monetization events. Bloom Burton and its affiliates provide capital
raising, M&A advisory, equity research, business strategy and scientific
consulting, advisory on direct investing and company creation and
incubation services. Bloom Burton Securities Inc. is a member of the
Investment Industry Regulatory Organization of Canada (IIROC) and is
also a member of the Canadian Investor Protection Fund (CIPF).
About Greenbrook TMS Inc.
Operating through 70 Company-operated treatment centers,
Greenbrook is a leading provider of TMS, an FDA-cleared, non-invasive
therapy for the treatment of Major Depressive Disorder and other mental
health disorders, in the United States. TMS therapy provides local
electromagnetic stimulation to specific brain regions known to be
directly associated with mood regulation. Greenbrook has provided more
than 220,000 TMS treatments to over 6,000 patients struggling with
Chief Financial Officer, Treasurer and Corporate
Greenbrook TMS Inc.
Greenbrook TMS Inc.